BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 613561)

  • 21. Time course of changes in plasma renin after blockade of the renin-system. Studies of conscious and anaesthetized, normal, adrenalectomized and spontaneously hypertensive rats.
    Bing J; Poulsen K
    Acta Pathol Microbiol Scand A; 1975 Sep; 83(5):454-66. PubMed ID: 170788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of saralasin to evaluate the function of the brain renin-angiotensin system.
    Reid IA
    Prog Biochem Pharmacol; 1976; 12():117-34. PubMed ID: 1019160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologic studies with saralasin in animals.
    Gavras H; Gavras I; Brunner HR; Liang CS
    Kidney Int Suppl; 1979 Mar; (9):S20-8. PubMed ID: 384069
    [No Abstract]   [Full Text] [Related]  

  • 24. Physiologic determinants and clinical applications of angiotensin II blockade in hypertensive disorders.
    Parra-Carrillo JZ; Baer L; Radichevich I
    Cardiovasc Clin; 1978; 9(1):183-95. PubMed ID: 667880
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrarenal formation of angiotensin II in the rat: interference by Saralasin and SQ 20881.
    Zschiedrich H; Hofbauer KG; Hackenthal E; Baron GD; Gross F
    Clin Sci Mol Med Suppl; 1975 Jun; 2():37s-40s. PubMed ID: 1077787
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin inhibitors for hypertension.
    Gavras H; Gavras I; Brunner HR
    Compr Ther; 1980 May; 6(5):14-8. PubMed ID: 6155240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacologic functional examination in arterial hypertension].
    Stumpe KO; Kolloch R; Overlack A
    Internist (Berl); 1977 Nov; 18(11):594-600. PubMed ID: 23361
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inhibition of the renin-angiotensin system in treating arterial hypertension].
    Fagard R; Leuven KU; Staessen J; Amery A
    Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041
    [No Abstract]   [Full Text] [Related]  

  • 29. Essential hypertension: new concepts in diagnosis and treatment.
    Laragh JH
    Compr Ther; 1978 Dec; 4(12):10-7. PubMed ID: 738008
    [No Abstract]   [Full Text] [Related]  

  • 30. Combined intrarenal renin-angiotensin blockade alters renal function and this is reversed by angiotensin II.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    J Hypertens Suppl; 1989 Dec; 7(6):S174-5. PubMed ID: 2698923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new look at the hypertension problem: the role of the renin system for analysis and treatment.
    Laragh JH
    Compr Ther; 1985 Oct; 11(10):6-17. PubMed ID: 3902342
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical application of peptides with inhibition of renin-angiotensin system (author's transl)].
    Ogihara T
    Horumon To Rinsho; 1980; 28(3):275-83. PubMed ID: 6156788
    [No Abstract]   [Full Text] [Related]  

  • 33. Central hypertensive actions of angiotensin.
    Vollmer R; Buckley JP; Solomon TA; Jandhyala BS
    Acta Physiol Lat Am; 1974; 24(5):582-6. PubMed ID: 4377510
    [No Abstract]   [Full Text] [Related]  

  • 34. Editorial: New prospects in renal hypertension.
    Br Med J; 1975 Jul; 3(5975):59-60. PubMed ID: 1139228
    [No Abstract]   [Full Text] [Related]  

  • 35. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Historical development of saralasin.
    Pals DT; Denning GS; Keenan RE
    Kidney Int Suppl; 1979 Mar; (9):S7-10. PubMed ID: 384071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of the role of angiotensin inhibitors in delineating the function of the renin-angiotensin system.
    McCaa RE
    Prog Biochem Pharmacol; 1980; 17():29-35. PubMed ID: 7010367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Angiotensin blockade in the diagnosis of hypertension].
    Keim HJ; Case DB; Wallace JM; Sealry JE; Laragh JH
    Verh Dtsch Ges Kreislaufforsch; 1977; 43():205-6. PubMed ID: 613573
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polypeptides and antagonists].
    Regoli D
    Sem Hop; 1984 Mar; 60(14):987-1002. PubMed ID: 6202006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The brain renin angiotensin system in central cardiovascular control.
    Ganten D; Paul M; Deboben A; Unger T; Lang RE
    Contrib Nephrol; 1984; 43():114-28. PubMed ID: 6207981
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.